【24h】

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience

机译:Carpentier-Edwards心包阀在主动脉位置:25年的经验

获取原文
           

摘要

Statistical AnalysisPreoperative ParametersResultsSurvival and Functional StatusValve-Related Complications and ReoperationEffect of Age on Survival and ReoperationEffect of Concomitant CABG ProcedureEchocardiographic Follow-UpCommentStudy LimitationsConclusionsReferencesThe Carpentier-Edwards pericardial valve was designed to minimize structural valve deterioration. Excellent durability and low incidence of valve-related complications have been reported. The objective of the present study was to analyze clinical results after 25 years of experience with this valve implanted in the aortic position. The effect of patient age at the time of surgery was also evaluated.MethodsThis is a retrospective cohort study of 2,405 patients from November 1981 to March 2011. Primary outcomes of interest were survival and freedom from major adverse effects such as thromboembolic, endocarditis, and reoperation.ResultsSixty percent were male, with a mean age of 71?± 9 years old. Actuarial survival rates including early deaths averaged 78% ± 2%, 55% ± 2%, and 16 % ± 2% after 5, 10, and 20 years of follow-up, respectively. The freedom rate of valve reoperation for prosthesis dysfunction and all other causes averaged 98 % ± 0.2%, 96% ± 1%, and 67% ± 4% at 5, 10, and 20 years. Patients younger than 60 years of age had a 15-year survival averaging 54% ± 5% compared with patients aged between 60 and?70 years of age averaging 46% ± 3% and with patients?older than 70 years of age averaging 28% ± 3% (p?= 0.001). Survival at 5, 10, and 20 years for patients who had concomitant CABG [coronary artery bypass grafting] were 78% ± 1%, 55% ± 2%, and 9% ± 3% compared with no concomitant CABG (84% ± 1%, 62% ± 2%, and 22% ± 3% (p < 0.001)).ConclusionsCarpentier-Edwards pericardial valve implantation in the aortic position is secure and durable. The effects of age influence reoperation rate and survival as well as a concomitant coronary artery bypass procedure.CTSNet classification:35Adult Cardiac Surgery:The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/home. To take the CME activity related to this article, you must have either an STS member or an individual non-member subscription to the journal.Biologic valves from porcine or glutaraldehyde-treated bovine pericardium procure good hemodynamic profile similar to native valves. Biologic valves are a popular choice for implantation in patients older than 65 years of age [
机译:统计分析术前参数结果生存和功能状态瓣膜相关并发症和再手术年龄对生存和再手术的影响伴随CABG程序的超声心动图随访研究的局限性结论参考文献Carpentier-Edwards心包膜瓣膜的设计旨在最大程度地减少瓣膜结构的恶化。据报道,它具有出色的耐久性,并且与瓣膜相关的并发症发生率低。本研究的目的是分析将这种瓣膜植入主动脉位置25年的经验后的临床结果。方法这是一项回顾性队列研究,研究对象为1981年11月至2011年3月的2,405例患者。研究的主要终点是生存率和免受重大不利影响(如血栓栓塞,心内膜炎和再次手术)的影响。结果男性占60%,平均年龄为71±9岁。随访5年,10年和20年后,包括早期死亡在内的精算生存率平均为78%,±2%,55%,±2%和16%,±2%,分别。假体功能障碍和所有其他原因的瓣膜再手术的自由率在5、10和10时平均为98 %±0.2 %,96 %±1 %和67 %±4 % 20年。与60岁至70岁的患者平均46%±3%和年龄较大的患者相比,年龄小于60岁的患者的15年平均存活率为54% 5%。超过70岁,平均28%±3%(p?= 0.001)。伴有CABG [冠状动脉搭桥术]的患者在5、10和20岁时的存活率为78 %±1 %,55 %±2 %和9 %±3 与无伴随CABG相比为%(84 %±1 %,62 %±2 %和22 %±3 %(p <0.001))。结论Carpentier-Edwards心包膜瓣膜在主动脉位置植入是安全和持久的。年龄的影响会影响再手术率和生存率,并伴有冠状动脉搭桥手术。CTSNet分类:35成人心脏外科手术:《胸外科史》 CME计划可在线访问http://www.annalsthoracicsicsryry.org/cme/home 。要从事与本文相关的CME活动,您必须具有STS会员或个人非会员订阅。来自猪或戊二醛处理过的牛心包的生物瓣膜具有与天然瓣膜相似的良好血液动力学特征。对于65岁以上的患者,生物瓣膜是植入的普遍选择[

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号